Zymeworks Inc (NAS:ZYME)
$ 14.5 0 (0%) Market Cap: 998.72 Mil Enterprise Value: 721.77 Mil PE Ratio: 0 PB Ratio: 2.75 GF Score: 73/100

Zymeworks Inc Investor Call Transcript

Apr 18, 2023 / 10:30PM GMT
Release Date Price: $9.98 (-2.35%)
Operator

Good day, and thank you for standing by. Welcome to the Zymeworks AACR Webcast and Conference Call. (Operator Instructions)

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Ken Galbraith, Chair and CEO. Please go ahead.

Kenneth H. Galbraith
Zymeworks Inc. - CEO & Chairman of the Board

Thank you. Good afternoon, everyone. Thank you all for dialing in. I'm Ken Galbraith, the Chair and CEO of Zymeworks. I'd like to welcome you to our AACR Conference Call and Webcast to discuss the exciting events presented and discussed at AACR over the past few days. We sincerely appreciate you taking the time out of your busy schedule to join us virtually.

Before I hand the call over to Paul Moore, our Chief Scientific Officer, and his team, I want to highlight some housekeeping matters. In today's presentation, we will be making forward-looking statements. We rely upon standard safe harbor disclosures, common in companies in our sector and state of development. For more

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot